Genome-wide association studies on serum sex steroid levels

Abstract

Even though the levels of circulating sex steroid hormones are to a large extent heritable, their genetic determinants are largely unknown. With the advent of genome-wide association studies (GWAS), much progress has been made and several genetic loci have been identified to be associated with serum levels of dehydroepiandrosterone sulfate, testosterone and sex hormone-binding globulin. The variants identified so far only explain a small amount of the overall heritability, but may help to elucidate the role of sex steroid hormones in common disorders such as hypogonadism, type 2 diabetes and hormone-sensitive cancers. This review provides an overview of the current state of knowledge of the genetic determinants of sex steroid hormones, with a focus on recent GWAS and brief directions for elucidating the remaining heritability.

Introduction

The primary source of the active sex steroids testosterone and estradiol in men and women are the testes and the pre-menopausal ovaries, respectively. Dehydroepiandrosterone sulfate (DHEAS), mainly secreted by the adrenal gland, is the most abundant circulating steroid in humans. It acts as an inactive precursor which is converted initially into DHEA and thereafter into active androgens in peripheral target tissues (Labrie et al., 2003). Testosterone is converted by the 5α-reductase enzyme into the more potent androgen dihydrotestosterone. Testosterone can also be converted into estradiol by the aromatase (CYP19A1) enzyme. Therefore, the actions of testosterone can be mediated via testosterone directly or dihydrotestosterone via the androgen receptor (AR) or by estradiol acting via estrogen receptor (ER) α or β. The active sex steroids are largely bound to two plasma proteins. Most of the circulating testosterone and estradiol (50–60%) is bound with high affinity to sex hormone-binding globulin (SHBG), which regulates the free levels of the active sex steroids. A smaller fraction (40–50%) is bound loosely to albumin whereas 1–3% is unbound and termed free sex steroids (Kaufman and Vermeulen, 2005). The combined free and albumin-bound fraction is often referred to as the bioavailable sex steroid fraction.

Serum sex steroid concentrations are subject to regulation at the genetic level as well as having environmental influences (Ring et al., 2005). Previous studies investigating racial differences in sex steroid levels (Gapstur et al., 2002, Litman et al., 2006, Santner et al., 1998) were not consistent and difficult to interpret because of small study sizes and the use of sex steroid assays with questionable specificity at lower concentrations. Environmental factors, including smoking, alcohol consumption, physical activity and especially dietary intake, have also been implicated in regulating serum sex steroid levels (Wang et al., 2007). Geographical and racial variation in serum sex steroid levels was thoroughly addressed by Orwoll et al. in a large international study of 5000 older men from five different countries (Orwoll et al., 2010). Levels of serum androgens, estrogens, and sex steroid precursors/metabolites were measured using the golden standard mass spectrometry technique. Asian men living in Hong Kong and Japan, but not in the United States, had higher testosterone levels, yet this difference was explained by differences in body mass index between the various populations. In addition, several racial differences were noted, with serum estradiol levels being higher in Black men compared to Asian and Caucasian men. This observation was associated with a higher estradiol to testosterone ratio in Black men, suggestive of higher aromatase activity in this population. Asian men also had lower levels of glucuronidated androgen metabolites (Orwoll et al., 2010).

A detailed analysis of the genetic variability of serum sex steroid levels had not been performed before the genome-wide association studies (GWAS) era. The Cohorts for Heart and Aging Research in Genetic Epidemiology (CHARGE) consortium (http://web.chargeconsortium.com) was established to facilitate GWAS meta-analyses among multiple large and well-phenotyped longitudinal cohort studies (Psaty et al., 2009). Within this consortium, a sex hormones working group was established in 2010 to investigate the genetic determinants of serum sex steroid levels.